Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2012, Issue , 2012, Pages 553-560

  Constantinescu, Stefan N ^a   Vainchenker, William ^b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; JAK2 PROTEIN, HUMAN; JANUS KINASE 2; STAT1 PROTEIN;

ALLELE; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG DESIGN; DRUG EFFECT; FIBROSIS; GENETIC EPIGENESIS; GENETICS; HEMATOLOGY; HUMAN; METABOLISM; METHODOLOGY; MUTATION; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; REVIEW; SPLICEOSOME;

ALLELES; CELL PROLIFERATION; DRUG DESIGN; EPIGENESIS, GENETIC; FIBROSIS; HEMATOLOGY; HUMANS; JANUS KINASE 2; MUTATION; MYELOPROLIFERATIVE DISORDERS; PRIMARY MYELOFIBROSIS; RECEPTORS, CYTOKINE; SPLICEOSOMES; STAT1 TRANSCRIPTION FACTOR;

MLCS; MLOWN;

EID: 84879342780     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation.v2012.1.553.3800163     Document Type: Review

References (0)